China SXT Pharmaceuticals

SXTCNasdaq China Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.264 M

$2.47 +3.78%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$6.21M

Loss-making

Shares outstanding

958,077

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#481HCW BiologicsHCWB$3.32M
#482RedHill BiopharmaRDHL$3.29M
#483China SXT PharmaceuticalsSXTC$3.26M
#484Alaunos TherapeuticsTCRT$3.23M
#485Silo PharmaSILO$3.02M

What if China SXT Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.2T

$22,878,938

Per share 9,262,728× higher

Bitcoin $1.74T

$1,317,962

Per share 533,588× higher

Nvidia $5.52T

$4,173,944

Per share 1,689,856× higher

Or at a round number

$5.00M $10.0M $20.0M $50.0M

Where these numbers come from

Share counts and financials for China SXT Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.